Interclean Shanghai

Chulalongkorn University hospital in South East Asia migrates to 3D Brachytherap

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Nucletron, the world leader in brachytherapy, announced that the third major University Hospital in Asia has migrated their brachytherapy program from basic 2D treatment planning to advanced 3D treatment planning, using the latest brachytherapy solutions from Nucletron.

The Chulalongkorn University Hospital in Bangkok/Thailand treated their first gynecologic patient last week, using their newly acquired microSelectron® Digital remote afterloader, Oncentra® Brachy 3D brachytherapy treatment planning solution, and a range of Nucletron’s CT-MR GYN applicators. Nucletron helped the hospital to perform the treatment planning using MRI information fused into CT images.

Dr. Chonlakiet, Radiation Therapist at the Chulalongkorn Hospital says, It is an exciting experience to have MRI assisted brachytherapy with the latest advanced 3 D treatment planning for our patients.

This makes the Chulalongkorn Hospital the third University Hospital that has introduced Nucletron’s advanced treatment solutions for patients in Asia. Last year, the National University Hospital in Singapore also migrated their brachytherapy program from 2D treatment planning to 3D treatment planning, allowing them to assess the dose delivered to the target and the critical organs more accurately.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »